Incidence of new coronary events in older persons with diabetes mellitus and prior myocardial infarction treated with sulfonylureas, insulin, metformin, and diet alone.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  American Journal of Cardiology

• Publication date

  2001-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0002-9149(01)01739-8PMID 11524069
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.

  1999cited by this paper
• Relation between sulfonylurea therapy, complications, and outcome for elderly patients with acute myocardial infarction.

  1999cited by this paper
• Report of the expert committee on the diagnosis and classification of diabetes mellitus.

  1999cited by this paper
• Sudden cardiac death.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• The optimal mode of coronary revascularization for diabetics. A risk-adjusted long-term study comparing coronary angioplasty and coronary bypass surgery.

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• The sixth report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited.

  1997cited by this paper
• Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

  1997cited by this paper
• The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

  1997cited by this paper
• Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease. Time for reconsideration.

  1996cited by this paper
• Glibenclamide prevents coronary vasodilation induced by beta 1-adrenoceptor stimulation in dogs.

  1994cited by this paper
• Ischemic Preconditioning During Coronary Angioplast Is Prevented by Glibenclamide, a Selective ATP‐Sensitive K+ Channel Blocker

  1994cited by this paper
• Prevalence of presenting symptoms of recognized acute myocardial infarction and of unrecognized healed myocardial infarction in elderly patients.

  1987cited by this paper
• Sudden cardiac death: definitions and causes.

  1986cited by this paper
• A Summary of Criticisms of the Findings and Conclusions of the University Group Diabetes Program (UGDP)

  1972cited by this paper
• Tables of average weight and height of Americans aged 65 to 94 years: relationship of weight and height to survival.

  1960cited by this paper

• Association of Metformin with the Mortality and Incidence of Cardiovascular Events in Patients with Pre-existing Cardiovascular Diseases

  2022cites this paper
• Heart failure in the patient with diabetes: Epidemiology, aetiology, prognosis, therapy and the effect of glucose‐lowering medications

  2019cites this paper
• Drug Treatment of Stable Coronary Artery Disease

  2016cites this paper
• Current treatment of hypertension in patients with coronary artery disease recommended by different guidelines

  2016cites this paper
• Beyond Metformin: Safety Considerations in the Decision-Making Process for Selecting a Second Medication for Type 2 Diabetes Management

  2014cites this paper
• Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations

  2014cites this paper
• Individualization of oral antidiabetic therapy in patients with type 2 diabetes

  2013cites this paper
• Cardiovascular risk factor management of myocardial infarction patients with and without diabetes in the Netherlands between 2002 and 2006: a cross-sectional analysis of baseline data

  2012cites this paper
• Diabetes Mellitus and Cardiovascular Disease

  2011cites this paper
• Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a population-based cohort study in Italy

  2011cites this paper
• Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case–control study

  2011cites this paper
• Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction.

  2010cites this paper
• CHAPTER 41 – Diagnosis and Management of Coronary Artery Disease

  2010cites this paper
• Outcomes in Diabetic Patients with Acute Myocardial Infarction Impact of Type of Preadmission Sulfonylureas on Mortality and Cardiovascular

  2010cites this paper
• The Role of Cardiac Rehabilitation in Achieving Optimal Treatment

  2010cites this paper
• Der Einfluss der porenbildenden Untereinheit des K ATP - Kanals auf die pharmakologischen Eigenschaften des Sulfonylharnstoffrezeptors SUR2B(Y1206S)

  2009cites this paper
• Management of the older patient after myocardial infarction

  2008cites this paper
• Острыйкоронарный синдром у больных сахарным диабетом: на пути к Мюнхену-2008

  2008cites this paper
• Effect of adenosine triphosphate-sensitive potassium channel inhibitors on coronary metabolic vasodilation.

  2007cites this paper
• Treatment After Myocardial Infarction

  2007cites this paper
• Association of Diet Alone, Insulin, Sulfonylureas, Metformin, and Thiazolidinediones with the Severity of Coronary Artery Disease in Patients with Diabetes Mellitus

  2006cites this paper
• The E23K polymorphism in Kir6.2 gene and coronary heart disease.

  2006cites this paper
• Sulfonylureas and the risk of myocardial infarction.

  2006cites this paper
• [Therapy with oral antidiabetic agents -- special considerations in the case of coronary heart disease].

  2005cites this paper
• Role of previous treatment with sulfonylureas in diabetic patients with acute myocardial infarction: results from a nationwide French registry

  2005cites this paper
• Therapie mit oralen Antidiabetika - Besonderheiten bei koronarer Herzerkrankung

  2005cites this paper
• Oral sulfonylureas and CV mortality.

  2004cites this paper
• The UGDP Controversy: thirty-four years of contentious ambiguity laid to rest

  2004cites this paper
• The impact of ATP-sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium.

  2004cites this paper
• Management of diabetes and hyperglycemia in hospitals.

  2004cites this paper
• The UGDP Story The UGDP was the brainchild of Max Miller of Case Western Reserve

  2004cites this paper
• Management of the elderly person after myocardial infarction.

  2004cites this paper
• Sulfonylureas in the prevention of vascular complications: from UKPDS to the ADVANCE study

  2003cites this paper
• Tratamento medicamentoso oral da hiperglicemia no diabete melito tipo 2

  2003cites this paper
• Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications.

  2003cites this paper
• Effect of ATP-Sensitive Potassium Channel Inhibition on Resting Coronary Vascular Responses in Humans

  2002cites this paper
• of metformin on mortality and cardiovascular events in patients with pre-existing

  year unknowncites this paper